Dementia, Alzheimer Type Clinical Trial
Official title:
Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)
The specific aims of this study are 1) to test the trial and intervention feasibility of Brain Care Notes (BCN) app, 2) To estimate the effect size of BCN on reducing informal caregiver burden at 6 months, and 3) To estimate the effect size of BCN on reducing patient behavioral and psychological symptoms of dementia (BPSD) at 6 months. Subjects will be recruited from the Aging Brain Care (ABC) program of Eskenazi Health and Indiana University Health located in central Indiana.
Informal caregivers of patients with Alzheimer's disease and related dementia (ADRD) manage a complex spectrum of patient behavioral and psychological symptoms of dementia (BPSD). BPSD are major contributing factors to caregivers' burden and adverse health outcomes, leading to an increase of unplanned hospitalizations and a decrease in quality of life. The National Alzheimer's Project Act recognizes the need for interventions that "enable family caregivers to continue to provide care while maintaining their own health and well-being." Furthermore, recommendations from 2015 and 2018 Alzheimer's Disease Research Summits include the application of technology to improve caregiving research and ADRD care This pilot randomized controlled trial, will test the feasibility and estimate the effect size of integrating mobile health technology BrainCare Notes (BCN) into an existing, fully operational, and self-sustaining clinical program (Aging Brain Care; ABC) and IU Health primary care physician clinics (IUHP). BCN is a mobile application (app) for informal caregivers of patients with Alzheimer's Disease and related dementia (ADRD). The BCN app delivers 24/7 psychoeducation and caregiver support, assessment of informal caregiver status and patients' behavioral and psychological symptoms of dementia (BPSD), and engagement tools for self-management and communication. Over a 15 month accrual period, we propose to enroll from the ABC clinical program and IUHP 60 dyads consisting of an adult patient with ADRD and one (primary) informal caregiver. The intervention will continue for 6 months and final assessments will be completed at 6 months. Feasibility data will be collected throughout the study and assessed at the end of the study by computing: (a) recruitment rate; (b) data completion; (c) BCN usability; (d) BCN acceptance; and (e) BCN use. Caregiver burden and patient BPSD will be collected at baseline, 3, and 6 months and evaluated for changes from baseline to 6 months in each group. Means, standard deviations, and confidence intervals will be computed to test feasibility hypotheses. Mixed linear models will be used to test hypotheses comparing the two conditions at 6 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT00154635 -
Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease
|
Phase 2 | |
| Completed |
NCT00208819 -
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
|
Phase 4 | |
| Completed |
NCT00997425 -
Home Evaluation of Exit Barriers in Wandering
|
N/A | |
| Terminated |
NCT02322021 -
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
|
Phase 2 | |
| Completed |
NCT00099242 -
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
|
Phase 3 | |
| Completed |
NCT03721705 -
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
|
Phase 3 | |
| Not yet recruiting |
NCT05113732 -
Association of Cognition With Functional Mobility in People With Alzheimer's Disease
|
||
| Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
| Completed |
NCT03160027 -
Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)
|
N/A | |
| Completed |
NCT03475316 -
Movement Intervention for Memory Enhancement
|
N/A | |
| Completed |
NCT02727699 -
A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
|
Phase 2 | |
| Completed |
NCT00259454 -
Project COPE:Managing Dementia at Home
|
Phase 3 | |
| Completed |
NCT00505167 -
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
|
Phase 4 | |
| Completed |
NCT03246269 -
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
|
||
| Recruiting |
NCT03890861 -
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
|
N/A | |
| Completed |
NCT03991195 -
Intervention of Intestinal Microorganism in Mild Cognitive Impairment
|
N/A | |
| Completed |
NCT00515333 -
TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
|
Phase 2 | |
| Completed |
NCT01438060 -
Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
|
Phase 3 | |
| Completed |
NCT03622814 -
Partners at Meals - Respite Care and Home (PAM)
|
N/A | |
| Recruiting |
NCT03672266 -
Studies of Brain and Body Interaction
|